This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frirdich, E.
Right arrow Articles by Whitfield, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frirdich, E.
Right arrow Articles by Whitfield, C.

 Previous Article  |  Next Article 

Journal of Bacteriology, June 2005, p. 4104-4115, Vol. 187, No. 12
0021-9193/05/$08.00+0     doi:10.1128/JB.187.12.4104-4115.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Characterization of GlaKP, a UDP-Galacturonic Acid C4-Epimerase from Klebsiella pneumoniae with Extended Substrate Specificity

Emilisa Frirdich and Chris Whitfield*

Department of Molecular and Cellular Microbiology, University of Guelph, Guelph Ontario, N1G 2W1, Canada

Received 25 January 2005/ Accepted 10 March 2005


arrow
ABSTRACT
 
In Escherichia coli and Salmonella enterica, the core oligosaccharide backbone of the lipopolysaccharide is modified by phosphoryl groups. The negative charges provided by these residues are important in maintaining the barrier function of the outer membrane. In contrast, Klebsiella pneumoniae lacks phosphoryl groups in its core oligosaccharide but instead contains galacturonic acid residues that are proposed to serve a similar function in outer membrane stability. GlaKP is a UDP-galacturonic acid C4-epimerase that provides UDP-galacturonic acid for core synthesis, and the enzyme was biochemically characterized because of its potentially important role in outer membrane stability. High-performance anion-exchange chromatography was used to demonstrate the UDP-galacturonic acid C4-epimerase activity of GlaKP, and capillary electrophoresis was used for activity assays. The reaction equilibrium favors UDP-galacturonic acid over UDP-glucuronic acid in a ratio of 1.4:1, with the Km for UDP-glucuronic acid of 13.0 µM. GlaKP exists as a dimer in its native form. NAD+/NADH is tightly bound by the enzyme and addition of supplementary NAD+ is not required for activity of the purified enzyme. Divalent cations have an unexpected inhibitory effect on enzyme activity. GlaKP was found to have a broad substrate specificity in vitro; it is capable of interconverting UDP-glucose/UDP-galactose and UDP-N-acetylglucosamine/UDP-N-acetylgalactosamine, albeit at much lower activity. The epimerase GalE interconverts UDP-glucose/UDP-galactose. Multicopy plasmid-encoded glaKP partially complemented a galE mutation in S. enterica and in K. pneumoniae; however, chromosomal glaKP could not substitute for galE in a K. pneumoniae galE mutant in vivo.


arrow
INTRODUCTION
 
Galacturonic acid (GalUA) is a major constituent of bacterial polysaccharides and plant cell walls. In bacteria, it can be found in capsule structures and as part of the lipopolysaccharide (LPS) molecule in several different bacterial species. LPS is a major virulence determinant in gram-negative bacteria (50). In the Enterobacteriaceae, the LPS molecule can be subdivided into three regions: (i) lipid A, the hydrophobic membrane anchor; (ii) a core oligosaccharide (core OS); and (iii) a polymer of glycosyl (repeat) units known as O polysaccharide (O-PS). Depending on the bacterial species, GalUA is found as a substituent on the ß-(1, 6)-linked GlcN disaccharide backbone of lipid A (73) and as a monosaccharide component of the core OS region (21) and the O-PS (28).

The Klebsiella pneumoniae LPS molecule (Fig. 1) shares significant similarity with the well-characterized LPS structures from other members of the Enterobacteriaceae, like Escherichia coli and Salmonella enterica (21, 50). However, one major feature distinguishing the K. pneumoniae core OS from that of E. coli and S. enterica is the absence of phosphoryl substitutions (Fig. 1). The negative charges provided by these phosphate residues in E. coli and S. enterica play an important role in maintaining the barrier function of the outer membrane (OM) by providing sites for divalent cations to cross-link adjacent LPS molecules (reviewed in reference 50). Mutants with highly truncated core OS structures lacking the inner core heptose-containing region display a pleiotrophic phenotype known as the deep-rough phenotype, characterized by changes in structure and composition of the OM (reviewed in references 18, 41, 42, and 56). In E. coli and Salmonella, these mutants show a decrease in the amount of OM proteins and a corresponding increase in phospholipids. These mutants are also hypersensitive to hydrophobic compounds, due to the appearance of phospholipids in the outer leaflet of the OM, which may facilitate rapid penetration of these compounds through the phospholipid bilayer regions of the membrane. Other characteristics of deep-rough mutants seen in E. coli include the release of periplasmic enzymes, the loss of cell surface organelles (e.g., pili and flagella), secretion of an inactive form of hemolysin, and the upregulation of colanic acid production (reviewed in reference 50). Precise mutations that eliminate core phosphorylation in E. coli and S. enterica serovar Typhimurium yield strains that exhibit some of the major characteristics of the deep-rough phenotype. They are characterized by an increase in susceptibility to hydrophobic compounds, but there is no alteration in OM protein profile (71, 72). The S. enterica serovar Typhimurium mutant also caused a complete attenuation of virulence in a mouse model (71).



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 1. The core OS structure of K. pneumoniae and E. coli K-12. The K. pneumoniae core OS structure is shown in panel A. Dashed arrows indicate nonstoichiometric substitutions. In K. pneumoniae these substitutions (residues J, K, and P) are comprised of ß-GalUA and Hep residues, and the various combinations detected in structural analyses are given below the structure (66, 67). The core OS structure of E. coli K-12 (21) is shown in panel B.

The core OS of K. pneumoniae contains GalUA residues as the only source of negative charge outside the lipid A-Kdo inner core domain. This is also the case in the core OS regions of Rhizobium etli and Rhizobium leguminosarum (14) and of Plesiomonas shigelloides O54 (40). In addition, some organisms have GalUA replacing the phosphate residues present on the lipid A moiety, such as R. etli (14), R. leguminosarum (6), and Aquifex pyrophilus (48). Interestingly, all these bacteria are environmental isolates, as is the case with K. pneumoniae (2). It has been proposed that having GalUA residues instead of phosphoryl substitutions may give these organisms an ecological advantage in habitats that are low in phosphate and low in the divalent cations involved in cross-linking adjacent LPS molecules, since carboxyl groups become more easily protonated, decreasing the repulsion between LPS molecules (41). Interestingly, the carboxyl groups on GalUA residues in homogalacturonan polymers (a component of pectic polysaccharides) in plant cell walls are cross-linked to each other by Ca2+ ions, contributing to the structural integrity of plant cell walls (reviewed in reference 43). Studies of mutants with LPS defects indicate that the carboxyl groups of the GalUA sugars in the core OS of K. pneumoniae provide the negative charge needed for OM stability (52; E. Frirdich, E. Vinogradov, and C. Whitfield, unpublished results).

Unlike other bacteria whose lipid A or inner core contains GalUA residues, K. pneumoniae is also an opportunistic pathogen. It is implicated in severe diseases, including urinary tract infections, pneumonia, and bacteremia, that are normally hospital acquired (reviewed in reference 49). The emergence of antibiotic-resistant K. pneumoniae strains, particularly extended-spectrum ß-lactamase-producing isolates that are difficult to treat, has renewed research on this pathogen in order to develop new therapeutic strategies (49). Since GalUA residues play a significant role in the biology of the LPS molecule of K. pneumoniae due to its importance in the maintenance of OM stability, the UDP-GalUA C4-epimerase involved in UDP-GalUA precursor synthesis was biochemically characterized.

UDP-GalUA is synthesized from UDP-Glc. UDP-Glc is first converted to UDP-glucuronic acid (GlcUA) by the UDP-glucose dehydrogenase (Ugd), converting the primary alcohol group to the corresponding acid. UDP-GlcUA is then converted to UDP-GalUA by the UDP-GalUA C4-epimerase (henceforth referred to as Gla). The K. pneumoniae UDP-GalUA C4-epimerase was originally named uge by another group of investigators (52). However, bacterial UDP-GalUA C4-epimerases were given the gene designation gla by the bacterial polysaccharide gene nomenclature system (http://www.microbio.usyd.edu.au/BPGD/default.htm) (51, 55), and Gla was adopted in this report with a subscript designating the organism, i.e., GlaKP for the gene from K. pneumoniae.


arrow
MATERIALS AND METHODS
 
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this study are summarized in Table 1. Bacteria were grown at 37°C in Luria-Bertani (LB) broth or in M9 minimal medium supplemented with 0.4% (wt/vol) glucose (33). Growth media were supplemented with chloramphenicol (15 µg/ml or 7.5 µg/ml), kanamycin (25 µg/ml), or streptomycin (200 µg/ml), as necessary. For mutant complementation, wild-type copies of glaKP and galE were expressed using pBAD-vector derivatives in the relevant mutant strains. Plasmid pBAD18-Km belongs to a family of expression vectors that use the arabinose-inducible and glucose-repressible araC promoter (17). For induction, a culture was grown at 37°C for 18 h in LB supplemented with either chloramphenicol or kanamycin and 0.4% (wt/vol) glucose. This culture was diluted 1:100 into fresh medium without glucose and grown until the culture reached an optical density at 600 nm of 0.2. 0.02% (wt/vol); L-arabinose was then added, and the culture was grown for another 2 h. Repressed controls were diluted 1:100 into fresh medium with 0.4% (wt/vol) glucose. For complementation studies using strains grown in M9 minimal medium containing 0.4% (wt/vol) glucose, induction was carried out with 0.6% (wt/vol) L-arabinose.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Bacterial strains and plasmids

DNA methods. Plasmid DNA was isolated using the Sigma GenElute Plasmid Miniprep Kit, and chromosomal DNA was prepared by the method of Hull et al. (22) or by using DNAzol Reagent (Invitrogen) in a modified protocol for bacteria (16). PCRs were performed in 0.05-ml volumes with either PwoI DNA polymerase (Roche) or Platinum Taq DNA polymerase (Invitrogen), using conditions optimized for the primer pair. Oligonucleotide primer synthesis and automated DNA sequencing were performed at the Guelph Molecular Supercentre (University of Guelph, Ontario, Canada). All PCR products were sequenced to verify that they were error free. Plasmids were maintained in E. coli DH5{alpha}, except for pRE112-derivatives that were maintained in DH5{alpha}[{lambda} pir]. For E. coli strains, transformation was carried out by electroporation and by methods described elsewhere (7). For some K. pneumoniae strains, a modification of the electroporation method was required (10, 16).

Insertion mutagenesis. The mutation in galE (CWG631) was constructed by insertion of the pRE112 plasmid into the galE gene on the K. pneumoniae chromosome, using methods described previously (39). Briefly, a pRE112-derivative containing a galE internal fragment was transformed into E. coli SM10[{lambda} pir] and then transferred by conjugation to the recipient strain, K. pneumoniae CWK2. The plasmid pRE112 requires the pir gene product to replicate (34), so in order for the plasmid to be maintained in CWK2, it must be integrated into the chromosome by homologous recombination within galE. CWK2 mutant derivatives in which pRE112 has been inserted into galE were selected by resistance to streptomycin (resistance carried by CWK2) and chloramphenicol (antibiotic marker on the plasmid).

The internal galE fragment was PCR amplified from K. pneumoniae CWK2 chromosomal DNA using primers KPwaa50 (5'-GCACGCCGGTACCATCTTC-3') and KPwaa51 (5'-GAGTCCGTCGCCAAGCCGCT-3'). The 431-bp PCR product was digested with KpnI (site underlined) and ligated to pRE112 digested with SmaI and KpnI to form pWQ73. The galE mutant was designated K. pneumoniae CWG631.

Plasmid constructs for GalE and Gla expression. The glaKP gene was amplified from K. pneumoniae CWK2 chromosomal DNA using primers KPwbnF13 (5'-cccaagcTTAGATCTGATAGTAATCCTTG-3') (lowercase letters indicate changes from the original genome sequence) and KPwbnF14 (5'-ggaattccatATGAAGTTTTTGGTCACTGG-3'). The 1,023-bp PCR product was digested by using HindIII and NdeI (sites underlined) and ligated into the same sites in pET28a(+) to make plasmid pWQ67. This plasmid expresses GlaKP with an in-frame six-histidine (His6) tag fused to the N terminus. For complementation studies, pWQ69 was constructed, in which the insert from pWQ67 was cloned in pBAD18-Km to facilitate expression in K. pneumoniae. The galE gene from K. pneumoniae was PCR amplified from CWK2 chromosomal DNA with primers KPwaa48 (5'-GACGATGTGcATGcTCAACGGGGT-3'; (lowercase letters indicate changes from the original genome sequence) and KPwaa49 (5'-CTGGCGTTCGcTagCAGTGGAGAC-3') as a 1,308-bp fragment. The PCR product was digested with NheI and SphI (sites underlined) and ligated into the same sites in pBAD18-Km to make plasmid pWQ72.

PAGE analysis. For polyacrylamide gel electrophoresis (PAGE) analysis, LPS was isolated from proteinase K-digested whole-cell lysates, as described by Hitchcock and Brown (19). The LPS was then separated on 4 to 12% Bis-Tris NuPAGE gels or 10 to 20% Tricine gels from Invitrogen and visualized by silver staining (65). For sodium dodecyl sulfate (SDS)-PAGE of proteins, the protein samples were solubilized in SDS-containing sample buffer (31) by boiling at 100°C for 15 min and then were separated on 12% SDS-PAGE gels. Proteins were visualized by Coomassie brilliant blue staining or by Western immunoblotting. For Western immunoblotting, proteins were transferred to nitrocellulose membranes (Pall Life Sciences) and probed with QIAGEN anti-pentahistidine mouse monoclonal antibodies according to the manufacturer's instructions. Colorimetric detection was used with a secondary goat anti-mouse antibody conjugated to alkaline phosphatase (Jackson ImmunoResearch Laboratories Inc.), visualized with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate.

GlaKP purification. The GlaKP protein was overexpressed from pWQ67 in E. coli BL21[{lambda}DE3]. This strain was grown at 37°C for 18 h in LB supplemented with kanamycin. The culture was then diluted 1:100 in 100 ml of fresh medium, and incubation was continued until the culture reached an optical density of 0.6 at 600 nm. Expression of His6-GlaKP was induced by adding isopropyl-1-thio-ß-D-galactopyranoside to the culture at a final concentration of 1 mM and continuing incubation for another 3.5 h. The cells were harvested, washed once in buffer A (50 mM NaH2PO4, pH 8.0, containing 300 mM NaCl) containing 10 mM imidazole, and then the pellet was frozen until required. The cell pellet was resuspended in 7 ml of buffer A containing 10 mM imidazole, and the cells were lysed by sonication. Unbroken cells and cell debris were removed by centrifugation (10 min at 20,000 x g). The membrane fraction was removed from the cleared lysate by ultracentrifugation (60 min at 100,000 x g). The supernatant was combined with 1 ml of 50% Ni2+-nitrilotriacetic acid (NTA) suspension (QIAGEN), and the mixture was incubated for 2 h at 4°C on a rotary shaker. The lysate-Ni2+-NTA mixture was then loaded into a disposable plastic column (5 ml) with elution by gravity flow. The column was washed twice with 10 column volumes of buffer A containing 15 mM imidazole. The protein was eluted with buffer A containing 250 mM imidazole, and approximately 2 ml of eluate was collected in 0.5-ml fractions. The fractions were examined by SDS-PAGE, and those with the highest amount of highest purity protein were pooled and dialyzed against 20 mM Tris-HCl, pH 8.0. AEBSF (4-[2-aminoethyl] benzenesulfonyl fluoride hydrochloride) (Sigma) protease inhibitors were added to a final concentration of 1 mM. The purified enzyme was stored at –80°C in 20% glycerol, without any loss of activity. Typical extracts contained 3 to 4 mg/ml protein.

Enzymatic activity of GlaKP. The enzymatic activity of GlaKP was assayed using a protocol adapted from Creuzenet et al. (8). Unless otherwise stated, the reaction mixture comprised 20 mM Tris-HCl, pH 8.0, buffer, containing 1 mM UDP-GlcUA substrate and 96.0 ng of purified GlaKP in a total of 0.05 ml. Reactions were carried out at 37°C and stopped by transfer of the reaction tubes to a boiling water bath for 6 min. The reaction products were separated by capillary electrophoresis (CE) using a Beckman P/ACE 5000 system (Beckman Instruments, Fullerton, CA) with UV detection at 254 nm. The running buffer was 25 mM sodium tetraborate, pH 9.5, and a bare silica capillary (75 µm by 57 cm) was used with a detector at 50 cm. The capillary was washed before each run for 2 min with 0.2 M NaOH, 2 min with water, and 4 min with running buffer. Samples were injected by pressure for 8 s and then separated at 22 kV. The Beckman P/ACE software was used for peak integration. For kinetic analyses, reactions were performed in a total of 0.05 ml of 20 mM Tris-HCl containing a range of 0.01 to 1.00 mM UDP-GlcUA and 12.0 ng of purified enzyme at 37°C for 3 min and then heated at 95°C for 6 min to quench the reaction. The initial rate conditions were selected to give less than 10% substrate conversion in 3 min. The reaction mixtures were analyzed by CE, and the kinetic parameters Km and the maximum rate of metabolism (Vmax) were calculated using the PRISM software (GraphPad Software Inc., San Diego, CA).

Properties of GlaKP. The molecular weight of purified His6-GlaKP was determined by matrix-assisted laser desorption ionization-time of flight mass spectrometry performed at the Biological Mass Spectrometry Facility, University of Guelph. The oligomerization status of GlaKP was determined on a Superose 12 HR 10/30 column (Amersham Biosciences) equilibrated with 50 mM Tris, pH 8.0, containing 100 mM NaCl. Protein elution was monitored at a wavelength of 280 nm. The column was calibrated with Sigma molecular mass standards (12.4 to 200 kDa). Two injections were carried out with a total of 50 µg and then 200 µg of His-GlaKP in a final volume of 0.2 ml.

In order to release NAD+/NADH bound by the enzyme, a total of 240 µg of GlaKP in 0.05 ml was treated with 10 µg of proteinase K for 1 h at 37°C. The products were analyzed by CE and compared to commercially available NAD+ and NADH standards available from Sigma. To verify the presence of NAD+ and NADH, one sample of proteinase K-digested GlaKP was spiked with 0.2 mM NAD+ and NADH.

The pH dependence was measured under standard assay conditions using 20 mM sodium acetate (pH 4.5, 5.0, and 5.5), 20 mM morpholineethanesulfonic acid (pH 6.0 and 6.5), 20 mM Tris-HCl (pH 7.0. 7.5, 8.0, 8.5, and 9.0), and 20 mM glycine-KOH (pH 9.5, 10.0, and 10.5) over 2 h. The temperature optimum was determined under standard assay conditions by measuring the amount of product formed in 2 h at 12, 20, 25, 30, 37, 45, 50, 55, and 65°C. To study the requirement for NAD+, reactions were carried out under standard conditions for 2 h with or without NAD+ (at a 1 mM final concentration). The influence of divalent cations (MgCl2, MnCl2, and CaCl2) was tested at final concentrations of 0 to 20 mM final concentrations.

HPAEC analysis of the GlaKP reaction products. The standard GlaKP assay was scaled up to a 0.25-ml reaction mixture containing 4 mM UDP-GlcUA substrate and 24.0 µg of purified GlaKP in 20 mM Tris-HCl, pH 8.0. Reactions were carried out for 2 h at 37°C and then stopped by hydrolysis of the UDP moiety. The samples were acidified to pH 2 with 0.05 ml of 0.1 N HCl, boiled for 5 min, and then neutralized with 0.05 ml of 0.1 N NaOH. The reaction products were then treated with 2 µl of alkaline phosphatase (20,000 U/ml; Amersham Pharmacia) for 2 h at 37°C. Protein was removed from the sample by filtration through a Microcon YM-3 0.5-ml centrifugal filter device (NMWL 3,000 Da; Millipore). Monosaccharides were then separated on a CarboPac PA1 column (4 mm by 250 mm; Dionex) by high-performance anion-exchange chromatography (HPAEC) on a Dionex BioLC system equipped with an electrochemical detector. Samples were resuspended in 10 mM NaOH, and a total of 10 nmol was injected. The column was washed for 2 min with 150 mM NaOH after injection, and the monosaccharides were eluted with a linear gradient of 0 to 25% 1 M sodium acetate in 150 mM NaOH over 38 min.


arrow
RESULTS
 
Identification of GlaKP. A putative UDP-GalUA C4-epimerase (GlaEC; WbnF) was identified in the O-PS biosynthesis gene cluster of E. coli O113 (45). The sequence of this open reading frame was used for a BLAST search of the unfinished genome of the clinical isolate K. pneumoniae MGH 78578 (http://genome.wustl.edu/projects/bacterial/kpneumoniae/). An open reading frame on CONTIG705 was identified showing 82% identity and 93% similarity at the amino acid level to GlaEC (WbnF) (accession number AAD50494.1). A portion of the K. pneumoniae homolog of Ugd was also encoded on CONTIG705. A genomic region of K. pneumoniae NTUH-K2044 was recently sequenced that contained genes involved in exopolysaccharide synthesis, sugar nucleotide precursor synthesis, and O-PS biosynthesis and export (11). The glaKP gene was found on this segment, although not annotated by the authors, and is located downstream of ugd and transcribed in the opposite orientation. Downstream of glaKP is a hypothetical protein of unknown identity, followed by the O-PS biosynthetic cluster.

As this work was in progress, the K. pneumoniae glaKP gene (named uge by the authors) of K. pneumoniae O1:K2 was identified by another group of investigators in a screen for mutants affecting capsule expression (52). They showed that a glaKP mutant strain lacked UDP-GalUA, but the GlaKP enzyme was not characterized.

GlaKP shares identity with several nucleotide sugar epimerases encoded by organisms containing GalUA-containing polymers. For example, it shares 53% identity and 67% similarity to GlaSM (LpsL) (accession number CAA10917.1) of Sinorhizobium meliloti (26, 27), 50% identity and 67% similarity to GlaSP (Cap1J) (accession number CAB05928) of S. pneumoniae (37, 38), and 47% identity and 64% similarity to GAE1 (accession number AAT77233) of Arabidopsis (35). The functions of all of these enzymes as UDP-GalUA epimerases have been shown in vitro (26, 35, 37).

GlaKP expression and purification. The GlaKP protein has a predicted molecular mass of 37,343.57 Da and a slightly acidic pI of 5.39. The His6-GlaKP protein has a predicted molecular mass of 39,506.81 Da, consistent with that determined by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis of the purified protein (39,524.88 Da). By SDS-PAGE analysis, most of the protein is present in the soluble fraction (Fig. 2A). It was expressed at approximately 3 to 4 mg/100 ml of culture, representing 49.9% of the total protein (Table 2). GlaKP was purified to near homogeneity by nickel chelation chromatography (Fig. 2B). The presence of the N-terminal His6 tag was verified by Western immunoblotting with an anti-pentahistidine monoclonal antibody (data not shown).



View larger version (29K):
[in this window]
[in a new window]
  		FIG. 2. Overexpression and purification of His6-GlaKP. (A) Coomassie blue-stained SDS-PAGE of the cell-free lysate, soluble fraction, and membrane fractions of E. coli BL21[{lambda}DE3] [pET28(+)] and E. coli BL21[{lambda}DE3] (pWQ67). Loading was adjusted to correspond to the original cell-free lysate so that the relative amounts of His6-GlaKP (4.3 µg) can be compared directly. (B) SDS-PAGE analysis of purified His6-GlaKP after Ni2+-NTA affinity chromatography. His6-GlaKP has a predicted size of 39 506.81 Da.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Purification table for GlaKP as determined by CE

Gel filtration chromatography showed that GlaKP has an apparent molecular mass of approximately 75,000 Da (data not shown), consistent with a dimeric structure.

HPAEC analysis of the GlaKP reaction products. To confirm the predicted activity of GlaKP, the reaction products were first treated with HCl and then dephosphorylated prior to HPAEC analysis. The resulting monosaccharides were readily separated by HPAEC (Fig. 3, trace A). Two peaks were identified in the reaction mixtures with elutions consistent with GlcUA and GalUA standards (Fig. 3, traces B and C, respectively). This analysis was consistent with the predicted UDP-GalUA C4-epimerase activity of GlaKP, converting UDP-GlcUA to UDP-GalUA. This reaction is likely reversible, as is the case with GlaSP (Cap1J) (37), but this was not tested since UDP-GalUA is no longer commercially available.



View larger version (15K):
[in this window]
[in a new window]
  		FIG. 3. HPAEC chromatogram of GlaKP reaction products after hydrolysis to release the UDP-moiety. Assay mixtures containing 4 mM UDP-GlcUA substrate and 24.0 µg of purified GlaKP were incubated for 2 h. The mixtures were treated with HCl to release the monosaccharides and then incubated with alkaline phosphatase. After removal of protein, the reaction products (A) were separated on a CarboPac PA1 column with a linear gradient of 0 to 25% 1 M sodium acetate. GlcUA (B) and GalUA (C) standards were run to confirm the identity of the reaction products.

CE analysis of GlaKP activity. The products of GlaKP activity were analyzed by CE, which showed the time-dependent appearance of a novel peak migrating faster than the UDP-GlcUA substrate peak. The product was determined to be UDP-GalUA by HPAEC analysis (Fig. 4A). At equilibrium, under these experimental conditions, GlaKP activity appeared to favor UDP-GalUA formation with a ratio of about 1.4:1 for the conversion of UDP-GlcUA to UDP-GalUA (Table 3). Time course experiments were carried out with different enzyme dilutions, showing a dependence of GlaKP activity on both time and enzyme concentration (Fig. 4B).



View larger version (23K):
[in this window]
[in a new window]
  		FIG. 4. Epimerization of UDP-GlcUA by GlaKP at equilibrium. The reactions were carried out in a total volume of 50 µl with 1 mM UDP-GlcUA and incubated at 37°C. Panel A shows the CE spectrum of assay mixtures after variation in incubation times. The upper trace is a control reaction containing no enzyme. Panel B demonstrates the dependence of GlaKP activity and product formation on time and enzyme concentration. Panel C illustrates the effect of divalent cations on GlaKP activity. Reactions were incubated for 2 h at 37°C with 1 mM UDP-GlcUA and 96.0 ng of GlaKP. AU, arbitrary units.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Substrate specificity and NAD+ requirement of GlaKPa

Biochemical characterization of GlaKP. GlaKP has activity over a wide pH range with an optimum pH of ~7.5 to 8.0 (data not shown). It is also active over a broad range of temperatures, with an optimum between 30 to 45°C (data not shown). The addition of exogenous NAD+ had no effect on enzyme activity (Table 3), as was the case with GlaSP (Cap1J) from S. pneumoniae (37). However, NAD+ is likely an essential coenzyme, as it was shown to be required for the mechanism of C4 epimerization described for GalE. In GalE isolated from E. coli or yeast cells, NAD+ is tightly bound to the enzyme and does not dissociate (reviewed in reference 15). Therefore, GlaKP was digested with proteinase K to release any bound cofactor. Peaks corresponding to NAD+ and NADH were seen on the CE spectrum of the digestion products (data not shown), indicating that NAD+ is also bound by GlaKP. Divalent cations had an unexpected effect on GlaKP activity (Fig. 4C). CaCl2, MgCl2, and MnCl2 were all inhibitory toward conversion of UDP-GlcUA to UDP-GalUA. The most drastic effect was seen with MnCl2, which caused total inhibition at a concentration of 5 mM. This type of effect has not been seen with other epimerases. For example, the UDP-Gal C4-epimerase GalE from E. coli (70) and the UDP-GlcNAc C4-epimerase WbpP of Pseudomonas aeruginosa (8) showed no change in activity with the addition of divalent cations.

The Km and Vmax values of GlaKP were determined from a Michaelis-Menten plot. GlaKP has a substantially higher affinity for the substrate UDP-GlcUA and is a more efficient enzyme than GlaSP (Cap1J) (Table 4). However, it is difficult to make detailed comparisons between the kinetic properties of the two enzymes, since they differ in enzyme stability, in the homogeneity of the protein preparations, and in the assays used to determine the kinetic parameters.


View this table:
[in this window]
[in a new window]
  		TABLE 4. Kinetic parameters of UDP-GalUA C4-epimerases from K. pneumoniae and S. pneumoniae

Relaxed substrate specificity of GlaKP. In addition to UDP-GlcUA, GlaKP was also found to be capable of reversible interconversion of UDP-Glc and UDP-Gal, as well as the acetamido derivatives UDP-GlcNAc and UDP-GalNAc (Table 3). The rate of conversion of UDP-Gal was much higher than that for UDP-Glc, with 79.8% UDP-Gal converted to UDP-Glc and only 38.9% UDP-Glc transformed to UDP-Gal at equilibrium with equivalent amounts of enzyme (data not shown). A shift toward UDP-Glc production at equilibrium was also reported for GalE (70). In contrast, the maximal conversion rates for UDP-GlcNAc and UDP-GalNAc were much lower, at 9.5% and 32.1% for UDP-GlcNAc and UDP-GalNAc, respectively. Interestingly, the amount of conversion of UDP-Gal to UDP-Glc was also higher than that of the optimal substrate UDP-GlcUA at the same enzyme concentration. A reaction time course showed that the conversion of UDP-Glc and UDP-Gal was time dependent (data not shown). This broader specificity distinguished GlaKP from GlaSP (Cap1J) since the latter showed no activity with either UDP-Glc or UDP-Gal (37). The kinetic parameters for GlaKP using UDP-Glc and UDP-Gal as substrates could not be determined because the enzyme was still not saturated at substrate concentrations of 24 mM (data not shown). This suggests that neither is likely to be an ideal substrate for the enzyme.

Examination of GlaKP activity in vivo. In order to examine the biological relevance of the action of GlaKP on UDP-Glc and UDP-Gal, glaKP was introduced on a plasmid into a S. enterica serovar Typhimurium galE mutant strain (Fig. 5). GalE is a well-characterized reversible UDP-Gal C4-epimerase involved in Gal metabolism. The core OS of S. enterica serovar Typhimurium contains Gal (21). When grown in minimal medium supplemented with Glc, S. enterica serovar Typhimurium SL1306 (galE) produces a truncated core OS that can no longer ligate O-PS; however, when Gal is present in the medium, UDP-Gal can be synthesized directly (rather than from epimerization of UDP-Glc), and core OS elongation and O-PS ligation are restored. When glaKP was expressed in SL1306 (pWQ69; GlaKP+), partial complementation of the mutation was evident (Fig. 5A, lane 5), consistent with the synthesis of a wild-type S. enterica serovar Typhimurium core OS, although this was not confirmed by structural studies. The presence of Glc in the medium would prevent full induction of glaKP by arabinose, but even under these suboptimal conditions the data clearly show that GlaKP can carry out the synthesis of UDP-Gal at physiological concentrations of UDP-Glc.



View larger version (42K):
[in this window]
[in a new window]
  		FIG. 5. NuPAGE gels (10 to 12%) showing the complementation of galE mutations in S. enterica serovar Typhimurium (SL1306) and in K. pneumoniae (CWG631) with pWQ69 (GlaKP +). Gene expression from complementing plasmids was induced by the addition of 0.6% arabinose to the medium. (A) PAGE analysis of S. enterica serovar Typhimurium mutant SL1306 and complementation with pWQ69 (GlaKP +). These strains were grown in M9 minimal medium supplemented with 0.4% glucose. In order to restore synthesis of the full-length core OS and O-PS addition in SL1306, 0.4% Gal was added. (B) PAGE analysis of K. pneumoniae CWG631 (galE) and complementation with pWQ72 (GalE+) and pWQ69 (GlaKP +). These strains were grown in LB and, in some cases, were supplemented with 0.4% Glc to repress Gal uptake from the medium.

The results in S. enterica serovar Typhimurium raised the question of whether GlaKP performed dual functions in K. pneumoniae. To address this, a galE mutant (CWG631) was constructed in K. pneumoniae. The galE gene was identified by a BLAST search of the unfinished genome of K. pneumoniae MGH 78578 (http://genome.wustl.edu/projects/bacterial/kpneumoniae/) based on its homology with the galE gene of E. coli K-12 (NP_451280.2). Primers were designed using the K. pneumoniae MGH 78578 sequence to PCR amplify the galE gene from K. pneumoniae CWK2. The nucleotide sequence of the 5' region of the galE gene from K. pneumoniae CWK2 is 98% identical to the corresponding region of the galE gene from strain CG43 (M94964.1; the 3' end of the CG43 galE has not been sequenced) (46). The activity of the galE gene product from K. pneumoniae CG43 has been characterized by complementation analysis (46). The GalE gene product of K. pneumoniae CWK2 shows 94% identity and 97% similarity and 92% identity and 97% similarity to GalE from S. enterica serovar Typhimurium (NP_459755.1) and E. coli K-12 (NP_451280.2), respectively. The O-PS of K. pneumoniae O1 CWK2 is a polymer of disaccharide repeat units containing galactopyranose and galactofuranose (29, 30, 68). The galE mutant (CWG631) produces full-length core OS lacking O-PS (Fig. 5B), consistent with the absence of UDP-Gal C4-epimerase. When Gal was added to the culture medium, O-PS synthesis was not restored. This can be explained by the anticipated polar effects of the galE::pRE112 insertion mutation on galK. The gal operon is synthesized from a polycistronic mRNA in the order of galE (epimerase), galT (galactose-1-phosphate uridyltransferase), and galK (galactokinase), as in E. coli and Salmonella (46). As expected, in the presence of GalE from a complementing plasmid, UDP-Gal formation can still occur and O-PS synthesis is restored, independent of GalK activity (Fig. 5B, lanes 4 and 5). CWG631 (galE) produces rough LPS, indicating that the chromosomal copy of glaKP cannot compensate for the mutation in galE. When pWQ69 (GlaKP+) was transformed into CWG631 (galE), only a slight amount of O-PS was added to the core OS (Fig. 5B, lane 9). Despite the small amount of O-PS formed under conditions where GlaKP is overexpressed in K. pneumoniae CWG631 (data not shown), the rough LPS phenotype of CWG631 (galE) provides convincing evidence that under physiological conditions, GlaKP activity cannot substitute for GalE to any significant extent.

The differences in the extent of GlaKP complementation of galE mutants in S. enterica serovar Typhimurium and K. pneumoniae may be explained by the amount of Gal required in each strain. Only two Gal residues are required for core OS completion in S. enterica serovar Typhimurium, whereas a large amount of Gal is required for synthesis of the polygalactan O-PS repeat unit in K. pneumoniae.


arrow
DISCUSSION
 
GlaKP plays an important role in the virulence of K. pneumoniae. Mutants in glaKP (uge) show enhanced susceptibility to hydrophobic compounds (52; E. Frirdich, E. Vinogradov, and C. Whitfield, unpublished results). However, correlating this phenotype to avirulence is not possible because the position of GalUA in the core OS backbone (Fig. 1) means that a glaKP mutant cannot ligate O-PS. In addition, the glaKP mutant strain did not produce capsular polysaccharide, even though the capsule structure of the wild-type K2 strain used to construct the mutant does not contain GalUA. Both O-PS and capsular polysaccharide are critical virulence determinants in K. pneumoniae (49), and the avirulence of the glaKP mutant could be due to either (or both) of these defects.

Proteins with UDP-GalUA C4-epimerase activities have been described in S. pneumoniae (Cap1J; GlaSP) (37), S. meliloti, (LpsL; GlaSM) (26), and in Arabidopsis (GAE1) (35). All of these enzymes have been shown to be UDP-GalUA epimerases in in vitro enzyme assays. GlaSP (Cap1J) was partially purified and was the first UDP-GalUA epimerase to be characterized at a biochemical level (37). However, attempts to purify GlaSP to electrophoretic homogeneity without loss of activity were unsuccessful. Biochemical characteristics are also available for GAE1 from Arabidopsis, although purified protein was not used in these assays (35). Interestingly, unlike bacterial UDP-GalUA C4-epimerases, the plant enzymes are predicted to be membrane proteins likely targeted to the Golgi, where they would supply UDP-GalUA to Golgi transferases involved in pectin biosynthesis (35).

GlaKP shares a high level of sequence similarity with nucleotide sugar epimerases and other members of the short-chain dehydrogenase/reductase (SDR) enzyme family of oxidoreductases (reviewed in references 25 and 44). The SDR family currently includes over 3,000 enzymes from all forms of life. Typically, they carry out oxidation-reduction reactions, usually functioning as dehydrogenases, dehydratases, isomerases, or epimerases. These enzymes share anywhere from 15 to 30% amino acid identity and display two conserved motifs (25, 44) that are present in GlaKP (Fig. 6). The first is a TGXXGXXG motif found in the N terminus which displays a conserved alternating {alpha}/ß-folding pattern typical of a Rossman fold involved in coenzyme (NAD+) binding (13, 53, 69). The second motif consists of the catalytic triad of Ser, Tyr, and Lys with the YXXXK motif, which has recently been extended to a catalytic tetrad of Asn, Ser, Tyr, and Lys (13). The Ser residue may be replaced by Thr in some members of the SDR family.



View larger version (135K):
[in this window]
[in a new window]
  		FIG. 6. Alignment of GlaKP, its bacterial homologs, and other characterized bacterial epimerases. The K. pneumoniae GlaKP was aligned with its homologs in E. coli O113 WbnF, S. meliloti LpsL, and S. pneumoniae Cap1J, as well as the UDP-GlcNAc epimerase WbpP from P. aeruginosa and the UDP-Gal epimerases from E. coli K-12 (designated K-12GalE) and from Homo sapiens (designated HSGalE). Crystal structures are available for these three enzymes (3, 23, 64). Identical amino acids are shown in black, and similar residues are boxed in gray. Underlined residues are involved in nucleotide binding (53, 69), and amino acids marked by an asterisk have been shown to be important for catalysis (13, 25, 44). Amino acids that are underlined twice are thought to be involved in substrate binding (23). Multiple alignments were performed with CLUSTAL_W available at the ExPASy molecular biology server (au.expasy.org).

GlaKP shows 24% identity and 43% similarity at the amino acid level to E. coli GalE (accession number NP_415280). Secondary structure predictions of GlaKP (data not shown) using PSIpred analysis (http://bioinf.cs.ucl.ac.uk/psipred/) (24) predict GlaKP to have a secondary structure very similar to that of the GalE enzyme of E. coli (3). GalE is subdivided into two domains with the N-terminal domain containing the typical Rossman fold with six ß-sheets surrounded by {alpha}-helices and a seventh ß-sheet in the C-terminal domain. The small C-terminal domain of GalE is involved in substrate binding, and this is probably also the case with GlaKP, based on overall structural similarity. The cleft between the two domains contains the active site (59-61). GlaKP was found to be a dimer by gel filtration, as is the case with GlaSP (Cap1J) (37), the UDP-GlcNAc epimerase WbpP of P. aeruginosa (8), and GalE from both E. coli (3) and Homo sapiens (63). In the GalE prototype, each subunit of the homodimer contains one molecule of NAD+ and one molecule of UDP-linked substrate (3, 63). NAD+ addition to GlaKP enzyme reactions had no effect on enzyme activity, but this cofactor was found to be bound to the enzyme, as was the case with GlaSP (Cap1J) from S. pneumoniae (37). The mechanism by which GalE catalyzes the C4-epimerization of UDP-Glc/UDP-Gal has been well characterized (1, 12, 15, 20). It involves formation of a transient keto-sugar intermediate with transient reduction of enzyme-bound NAD+. The mechanism by which GlaKP mediates the C4-epimerization of UDP-GlcUA/UDP-GalUA may be similar, given the overall amino acid similarity showed by GalE (from E. coli) and GlaKP, particularly the conservation of active site residues.

GlaKP UDP-GalUA C4-epimerase activity favors the formation of UDP-GalUA formation in a ratio of 1.4:1, which is similar to the equilibrium constant of 1.3 in the direction of UDP-GalUA formation reported for S. pneumoniae GlaSP (Cap1J) (37) and Arabidopsis GAE1 (35). However, GlaSP and GAE1 could not interconvert UDP-Glc/UDP-Gal (35, 37).

Some epimerases are known to have expanded substrate specificity, although this property has not been previously reported for a UDP-GalUA 4-epimerase. Interestingly, the mammalian form of GalE, unlike that of E. coli, can turn over UDP-GlcNAc and UDP-GalNAc in addition to UDP-Glc/UDP-Gal. This has been attributed to a larger (by approximately 15%) saccharide-binding site in the human enzyme and an amino acid substitution in the active site from Tyr299 in E. coli to Cys307 in the human form (Fig. 6, the last doubly underlined residue). This facilitates the accommodation of the N-acetyl group at the C2 position of the sugar (62, 64). It has also been shown that the Gne enzyme of Bacillus subtilis interconverts UDP-Glc and UDP-Gal, as well as (to a lesser extent) the N-acetylated forms of the substrates (58). These activities are seen in vitro and in vivo. The Gne enzyme of Campylobacter jejuni was recently shown to be a bifunctional UDP-Glc/GlcNAc epimerase with both in vitro and in vivo activity (5).

Several studies now suggest that the Tyr299 in E. coli GalE (Cys307 in the human GalE) is important in determining the size of the active site cleft, with smaller residues enabling the interconversion of larger substrates with or without compromising the conversion of smaller substrates (4, 23, 57, 62, 64). This residue has been termed a form of "gatekeeper" (57). The UDP-GlcNAc 4-epimerases WbpP from P. aeruginosa serotype O6 (8) and Gne from Yersinia enterocolitica serotype O8 (4) also have weak UDP-Gal 4-epimerase activity. A recent determination of the crystal structure of WbpP with UDP-GlcNAc and UDP-Glc reexamined the basis of substrate specificity of UDP-hexose C4-epimerases (23). In the case of WbpP, orbital steering is proposed to explain the preferential catalysis of UDP-GlcNAc/UDP-GalNAc over UDP-Glc/UDP-Gal (23, 32). The saccharide-binding pocket of WbpP is larger than that of GalE, due to the substitution of certain amino acids in the binding pocket (Fig. 6, double-underlined residues). According to the model, this allows water molecules to play a role in saccharide binding. The N-acetyl group permits the ordering of water molecules in the active site, thus stabilizing the saccharide group for catalysis. The same is not seen in nonacetylated substrates, and their conversion is not as efficient. Alignments of GlaKP homologs with WbpP and GalE show that the residues thought to be involved in the saccharide-binding pocket are conserved between UDP-GalUA 4-epimerases (including Arabidopsis GAE1 [data not shown]). However, there are differences compared to the corresponding residues present in WbpP and GalE (Fig. 6, underlined residues). The presence of Ala86, Thr180, and Thr298 in UDP-GalUA epimerases would potentially influence the size of the saccharide-binding pocket. It is therefore plausible that the preferential catalysis of UDP-GlcUA over UDP-Glc/UDP-Gal and UDP-GlcNAc/UDP-GalNAc epimerization may also reflect orbital steering. Nuclear magnetic resonance studies have shown that divalent cations (Mg2+, Mn2+, and Ca2+) may be involved in preorganizing the nucleotide sugar in enzymatic reactions (36). Binding studies on E. coli GalE have shown strong binding of the UDP group to the protein (reviewed in reference 15). The inhibitory action of divalent cations on GlaKP activity may be due to their influence on positioning of the nucleotide sugar in the active site.

While epimerases have been shown to act on various substrates in vitro, this activity is not always biologically relevant. For example, the UDP-Gal 4-epimerase activity of WbpP has not been detected under physiological conditions in P. aeruginosa (8). The Y. enterocolitica Gne enzyme was able to complement an E. coli K-12 galE mutation, but the importance of this activity in Y. enterocolitica was not established. Y. enterocolitica O8 does possess a "true" galE gene elsewhere on its chromosome (47). In the case of GlaKP of K. pneumoniae, UDP-Gal 4-epimerization activity could be demonstrated in vitro but does not play a significant role in vivo in K. pneumoniae.


arrow
ACKNOWLEDGMENTS
 
This work was financially supported by funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Bacterial Diseases Network (to C.W.). C.W. holds a Canada Research Chair, and E.F. received postgraduate scholarships from NSERC and CIHR.

The advice of A. R. Merrill (Department of Molecular and Cellular Biology, University of Guelph) concerning kinetic analysis of GlaKP is gratefully acknowledged.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada. Phone: (519) 824-4120, ext. 53361. Fax: (519) 837-1802. E-mail: cwhitfie{at}uoguelph.ca. Back


arrow
REFERENCES
 
    1
  1. Allard, S. T., M. F. Giraud, and J. H. Naismith. 2001. Epimerases: structure, function and mechanism. Cell. Mol. Life Sci. 58:1650-1665.[CrossRef][Medline]
    2. 2
  2. Bagley, S. T. 1985. Habitat association of Klebsiella species. Infect. Control 6:52-58.[Medline]
    3. 3
  3. Bauer, A. J., I. Rayment, P. A. Frey, and H. M. Holden. 1992. The molecular structure of UDP-galactose 4-epimerase from Escherichia coli determined at 2.5 Å resolution. Proteins 12:372-381.[CrossRef][Medline]
    4. 4
  4. Bengoechea, J. A., E. Pinta, T. Salminen, C. Oertelt, O. Holst, J. Radziejewska-Lebrecht, Z. Piotrowska-Seget, R. Venho, and M. Skurnik. 2002. Functional characterization of Gne (UDP-N-acetylglucosamine-4-epimerase), Wzz (chain length determinant), and Wzy (O-antigen polymerase) of Yersinia enterocolitica serotype O:8. J. Bacteriol. 184:4277-4287.[Abstract/Free Full Text]
    5. 5
  5. Bernatchez, S., C. M. Szymanski, N. Ishiyama, J. Li, H. C. Jarrell, P. C. Lau, A. M. Berghuis, N. M. Young, and W. W. Wakarchuk. 2004. A single bifunctional UDP-GlcNAc/Glc 4-epimerase supports the synthesis of three cell surface glycoconjugates in Campylobacter jejuni. J. Biol. Chem.
    6. 6
  6. Bhat, U. R., L. S. Forsberg, and R. W. Carlson. 1994. Structure of lipid A component of Rhizobium leguminosarum bv. phaseoli lipopolysaccharide. Unique nonphosphorylated lipid A containing 2-amino-2-deoxygluconate, galacturonate, and glucosamine. J. Biol. Chem. 269:14402-14410.[Abstract/Free Full Text]
    7. 7
  7. Binotto, J., P. R. MacLachlan, and P. R. Sanderson. 1991. Electrotransformation of Salmonella typhimurium LT2. Can. J. Microbiol. 37:474-477.[Medline]
    8. 8
  8. Creuzenet, C., M. Belanger, W. W. Wakarchuk, and J. S. Lam. 2000. Expression, purification, and biochemical characterization of WbpP, a new UDP-GlcNAc C4 epimerase from Pseudomonas aeruginosa serotype O6. J. Biol. Chem. 275:19060-19067.[Abstract/Free Full Text]
    9. 9
  9. Edwards, R. A., L. H. Keller, and D. M. Schifferli. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157.[CrossRef][Medline]
    10. 10
  10. Enderle, P. J., and M. A. Farwell. 1998. Electroporation of freshly plated Escherichia coli and Pseudomonas aeruginosa cells. BioTechniques 25:954-956, 958.[Medline]
    11. 11
  11. Fang, C. T., Y. P. Chuang, C. T. Shun, S. C. Chang, and J. T. Wang. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 199:697-705.[Abstract/Free Full Text]
    12. 12
  12. Field, R. A., and J. H. Naismith. 2003. Structural and mechanistic basis of bacterial sugar nucleotide-modifying enzymes. Biochemistry 42:7637-7647.[CrossRef][Medline]
    13. 13
  13. Filling, C., K. D. Berndt, J. Benach, S. Knapp, T. Prozorovski, E. Nordling, R. Ladenstein, H. Jornvall, and U. Oppermann. 2002. Critical residues for structure and catalysis in short-chain dehydrogenases/reductases. J. Biol. Chem. 277:25677-25684.[Abstract/Free Full Text]
    14. 14
  14. Forsberg, L. S., and R. W. Carlson. 1998. The structures of the lipopolysaccharides from Rhizobium etli strains CE358 and CE359. The complete structure of the core region of R. etli lipopolysaccharides. J. Biol. Chem. 273:2747-2757.[Abstract/Free Full Text]
    15. 15
  15. Frey, P. A. 1996. The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 10:461-470.[Abstract]
    16. 16
  16. Frirdich, E., E. Vinogradov, and C. Whitfield. 2004. Biosynthesis of a novel 3-deoxy-D-manno-oct-2-ulosonic acid-containing outer core oligosaccharide in the lipopolysaccharide of Klebsiella pneumoniae. J. Biol. Chem. 279:27928-27940.[Abstract/Free Full Text]
    17. 17
  17. Guzman, L.-M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose pBAD promoter. J. Bacteriol. 177:4121-4130.[Abstract/Free Full Text]
    18. 18
  18. Heinrichs, D. E., J. A. Yethon, and C. Whitfield. 1998. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Microbiol. 30:221-232.[CrossRef][Medline]
    19. 19
  19. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.[Abstract/Free Full Text]
    20. 20
  20. Holden, H. M., I. Rayment, and J. B. Thoden. 2003. Structure and function of enzymes of the Leloir pathway for galactose metabolism. J. Biol. Chem. 278:43885-43888.[Free Full Text]
    21. 21
  21. Holst, O. 1999. Chemical structure of the core region of lipopolysaccharides, p. 115-154. In H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison (ed.), Endotoxin in health and disease. Marcel Dekker, Inc., New York, N.Y.
    22. 22
  22. Hull, R. A., R. E. Gill, P. Hsu, B. H. Minshew, and S. Falkow. 1981. Construction and expression of recombinant plasmids encoding type I or mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect. Immun. 33:933-938.[Abstract/Free Full Text]
    23. 23
  23. Ishiyama, N., C. Creuzenet, J. S. Lam, and A. M. Berghuis. 2004. Crystal structure of WbpP, a genuine UDP-N-acetylglucosamine 4-epimerase from Pseudomonas aeruginosa: substrate specificity in UDP-hexose 4-epimerases. J. Biol. Chem. 279:22635-22642.[Abstract/Free Full Text]
    24. 24
  24. Jones, D. T. 1999. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292:195-202.[CrossRef][Medline]
    25. 25
  25. Jornvall, H., B. Persson, M. Krook, S. Atrian, R. Gonzalez-Duarte, J. Jeffery, and D. Ghosh. 1995. Short-chain dehydrogenases/reductases (SDR). Biochemistry 34:6003-6013.[CrossRef][Medline]
    26. 26
  26. Keating, D. H., M. G. Willits, and S. R. Long. 2002. A Sinorhizobium meliloti lipopolysaccharide mutant altered in cell surface sulfation. J. Bacteriol. 184:6681-6689.[Abstract/Free Full Text]
    27. 27
  27. Kereszt, A., E. Kiss, B. L. Reuhs, R. W. Carlson, A. Kondorosi, and P. Putnoky. 1998. Novel rkp gene clusters of Sinorhizobium meliloti involved in capsular polysaccharide production and invasion of the symbiotic nodule: the rkpK gene encodes a UDP-glucose dehydrogenase. J. Bacteriol. 180:5426-5431.[Abstract/Free Full Text]
    28. 28
  28. Knirel, Y. A., and N. K. Kochetkov. 1994. The structure of lipopolysaccharides of gram-negative bacteria. III. The structure of O-antigens: a review. Biochemistry 59:1325-1383.
    29. 29
  29. Kol, O., J.-M. Wieruszeski, G. Strecker, B. Fournet, R. Zalisz, and P. Smets. 1992. Structure of the O-specific polysaccharide chain of Klebsiella pneumoniae O1:K2 (NCTC 5055) lipopolysaccharide. A complementary elucidation. Carbohydr. Res. 236:339-344.[CrossRef][Medline]
    30. 30
  30. Kol, O., J.-M. Wieruszeski, G. Strecker, J. Montreuil, and B. Fournet. 1991. Structure of the O-specific polysaccharide chain from Klebsiella pneumoniae O1:K2 (NCTC 5055) lipopolysaccharide. Carbohydr. Res. 217:117-125.[CrossRef][Medline]
    31. 31
  31. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.[CrossRef][Medline]
    32. 32
  32. Mesecar, A. D., B. L. Stoddard, and D. E. Koshland, Jr. 1997. Orbital steering in the catalytic power of enzymes: small structural changes with large catalytic consequences. Science 277:202-206.[Abstract/Free Full Text]
    33. 33
  33. Miller, J. H. 1992. A short course in bacterial genetics. A laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
    34. 34
  34. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.[Abstract/Free Full Text]
    35. 35
  35. Molhoj, M., R. Verma, and W. D. Reiter. 2004. The biosynthesis of D-galacturonate in plants. Functional cloning and characterization of a membrane-anchored UDP-D-glucuronate 4-epimerase from Arabidopsis. Plant Physiol. 135:1221-1230.[Abstract/Free Full Text]
    36. 36
  36. Monteiro, C., S. Neyret, J. Leforestier, and C. Herve du Penhoat. 2000. Solution conformation of various uridine diphosphoglucose salts as probed by NMR spectroscopy. Carbohydr. Res. 329:141-155.[CrossRef][Medline]
    37. 37
  37. Muñoz, R., R. López, M. de Frutos, and E. Garcia. 1999. First molecular characterization of a uridine diphosphate galacturonate 4-epimerase: an enzyme required for capsular biosynthesis in Streptococcus pneumoniae type 1. Mol. Microbiol. 31:703-713.[CrossRef][Medline]
    38. 38
  38. Muñoz, R., M. Mollerach, R. Lopez, and E. Garcia. 1997. Molecular organization of the genes required for the synthesis of type 1 capsular polysaccharide of Streptococcus pneumoniae: formation of binary encapsulated pneumococci and identification of cryptic dTDP-rhamnose biosynthesis genes. Mol. Microbiol. 25:79-92.[CrossRef][Medline]
    39. 39
  39. Nesper, J., A. Kraiss, S. Schild, J. Blass, K. E. Klose, J. Bockemuhl, and J. Reidl. 2002. Comparative and genetic analyses of the putative Vibrio cholerae lipopolysaccharide core oligosaccharide biosynthesis (wav) gene cluster. Infect. Immun. 70:2419-2433.[Abstract/Free Full Text]
    40. 40
  40. Niedziela, T., J. Lukasiewicz, W. Jachymek, M. Dzieciatkowska, C. Lugowski, and L. Kenne. 2002. Core oligosaccharides of Plesiomonas shigelloides O54:H2 (strain CNCTC 113/92): structural and serological analysis of the lipopolysaccharide core region, the O-antigen biological repeating unit, and the linkage between them. J. Biol. Chem. 277:11653-11663.[Abstract/Free Full Text]
    41. 41
  41. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656.[Abstract/Free Full Text]
    42. 42
  42. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.[Free Full Text]
    43. 43
  43. O'Neill, M. A., T. Ishii, P. Albersheim, and A. G. Darvill. 2004. RHAMNOGALACTURONAN II: structure and function of a borate cross-linked cell wall pectic polysaccharide. Annu. Rev. Plant Biol. 55:109-139.[CrossRef][Medline]
    44. 44
  44. Oppermann, U., C. Filling, M. Hult, N. Shafqat, X. Wu, M. Lindh, J. Shafqat, E. Nordling, Y. Kallberg, B. Persson, and H. Jornvall. 2003. Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chem. Biol. Interact. 143-144:247-253.[CrossRef][Medline]
    45. 45
  45. Paton, A. W., and J. C. Paton. 1999. Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113. Infect. Immun. 67:5930-5937.[Abstract/Free Full Text]
    46. 46
  46. Peng, H. L., T. F. Fu, S. F. Liu, and H. Y. Chang. 1992. Cloning and expression of the Klebsiella pneumoniae galactose operon. J. Biochem. (Tokyo) 112:604-608.[Abstract/Free Full Text]
    47. 47
  47. Pierson, D. E., and S. Carlson. 1996. Identification of the galE gene and a galE homolog and characterization of their roles in the biosynthesis of lipopolysaccharide in a serotype O:8 strain of Yersinia enterocolitica. J. Bacteriol. 178:5916-5924.[Abstract/Free Full Text]
    48. 48
  48. Plotz, B. M., B. Lindner, K. O. Stetter, and O. Holst. 2000. Characterization of a novel lipid A containing D-galacturonic acid that replaces phosphate residues. The structure of the lipid A of the lipopolysaccharide from the hyperthermophilic bacterium Aquifex pyrophilus. J. Biol. Chem. 275:11222-11228.[Abstract/Free Full Text]
    49. 49
  49. Podschun, R., and U. Ullmann. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:589-603.[Abstract/Free Full Text]
    50. 50
  50. Raetz, C. R. H., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.[CrossRef][Medline]
    51. 51
  51. Reeves, P. R., M. Hobbs, M. A. Valvano, M. Skurnik, C. Whitfield, D. Coplin, N. Kido, J. Klena, D. Maskell, C. R. H. Raetz, and P. D. Rick. 1996. Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol. 4:495-503.[CrossRef][Medline]
    52. 52
  52. Regué, M., B. Hita, N. Pique, L. Izquierdo, S. Merino, S. Fresno, V. J. Benedi, and J. M. Tomas. 2004. A gene, uge, is essential for Klebsiella pneumoniae virulence. Infect. Immun. 72:54-61.[Abstract/Free Full Text]
    53. 53
  53. Rossman, M. G., and P. Argos. 1975. A comparison of the heme binding pocket in globins and cytochrome b5*. J. Biol. Chem. 250:7525-7532.[Abstract/Free Full Text]
    54. 54
  54. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
    55. 55
  55. Samuel, G., and P. Reeves. 2003. Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr. Res. 338:2503-2519.[CrossRef][Medline]
    56. 56
  56. Schnaitman, C. A., and J. D. Klena. 1993. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol. Rev. 57:655-682.[Abstract/Free Full Text]
    57. 57
  57. Schulz, J. M., A. L. Watson, R. Sanders, K. L. Ross, J. B. Thoden, H. M. Holden, and J. L. Fridovich-Keil. 2004. Determinants of function and substrate specificity in human UDP-galactose 4'-epimerase. J. Biol. Chem. 279:32796-32803.[Abstract/Free Full Text]
    58. 58
  58. Soldo, B., C. Scotti, D. Karamata, and V. Lazarevic. 2003. The Bacillus subtilis Gne (GneA, GalE) protein can catalyse UDP-glucose as well as UDP-N-acetylglucosamine 4-epimerisation. Gene 319:65-69.[CrossRef][Medline]
    59. 59
  59. Thoden, J. B., P. A. Frey, and H. M. Holden. 1996. Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli. Biochemistry 35:2557-2566.[CrossRef][Medline]
    60. 60
  60. Thoden, J. B., P. A. Frey, and H. M. Holden. 1996. High-resolution X-ray structure of UDP-galactose 4-epimerase complexed with UDP-phenol. Protein Sci. 5:2149-2161.[Medline]
    61. 61
  61. Thoden, J. B., P. A. Frey, and H. M. Holden. 1996. Molecular structure of the NADH/UDP-glucose abortive complex of UDP-galactose 4-epimerase from Escherichia coli: implications for the catalytic mechanism. Biochemistry 35:5137-5144.[CrossRef][Medline]
    62. 62
  62. Thoden, J. B., J. M. Henderson, J. L. Fridovich-Keil, and H. M. Holden. 2002. Structural analysis of the Y299C mutant of Escherichia coli UDP-galactose 4-epimerase. Teaching an old dog new tricks. J. Biol. Chem. 277:27528-27534.[Abstract/Free Full Text]
    63. 63
  63. Thoden, J. B., T. M. Wohlers, J. L. Fridovich-Keil, and H. M. Holden. 2000. Crystallographic evidence for Tyr 157 functioning as the active site base in human UDP-galactose 4-epimerase. Biochemistry 39:5691-5701.[CrossRef][Medline]
    64. 64
  64. Thoden, J. B., T. M. Wohlers, J. L. Fridovich-Keil, and H. M. Holden. 2001. Human UDP-galactose 4-epimerase. Accommodation of UDP-N-acetylglucosamine within the active site. J. Biol. Chem. 276:15131-15136.[Abstract/Free Full Text]
    65. 65
  65. Tsai, G. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.[CrossRef][Medline]
    66. 66
  66. Vinogradov, E., E. Frirdich, L. L. MacLean, M. B. Perry, B. O. Petersen, J. O. Duus, and C. Whitfield. 2002. Structures of lipopolysaccharides from Klebsiella pneumoniae. Elucidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains. J. Biol. Chem. 277:25070-25081.[Abstract/Free Full Text]
    67. 67
  67. Vinogradov, E., and M. B. Perry. 2001. Structural analysis of the core region of the lipopolysaccharides from eight serotypes of Klebsiella pneumoniae. Carbohydr. Res. 335:291-296.[CrossRef][Medline]
    68. 68
  68. Whitfield, C., J. C. Richards, M. B. Perry, B. R. Clarke, and L. L. MacLean. 1991. Expression of two structurally distinct D-galactan O-antigens in the lipopolysaccharide of Klebsiella pneumoniae serotype O1. J. Bacteriol. 173:1420-1431.[Abstract/Free Full Text]
    69. 69
  69. Wierenga, R. K., M. C. De Maeyer, and W. G. J. Hol. 1985. Interaction of pyrophosphate moieties with {alpha}-helices in dinucleotide binding proteins. Biochemistry 24:1346-1357.[CrossRef]
    70. 70
  70. Wilson, D. B., and D. S. Hogness. 1964. The enzymes of the galactose operon in Escherichia coli. I. Purification and characterization of uridine diphosphogalactose 4-epimerase. J. Biol. Chem. 239:2469-2481.[Free Full Text]
    71. 71
  71. Yethon, J. A., J. S. Gunn, R. K. Ernst, S. I. Miller, L. Laroche, D. Malo, and C. Whitfield. 2000. Salmonella enterica serovar Typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence in vivo. Infect. Immun. 68:4485-4491.[Abstract/Free Full Text]
    72. 72
  72. Yethon, J. A., D. E. Heinrichs, M. A. Monteiro, M. B. Perry, and C. Whitfield. 1998. Involvement of waaY, waaQ, and waaP in the modification of Escherichia coli lipopolysaccharide and their role in the formation of a stable outer membrane. J. Biol. Chem. 273:26310-26316.[Abstract/Free Full Text]
    73. 73
  73. Zähringer, U., B. Lindner, and E. T. Rietschel. 1999. Chemical structure of lipid A: recent advances in structural analysis of biologically active molecules, p. 93-114. In H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison (ed.), Endotoxin in health and disease. Marcel Dekker, Inc., New York, N.Y.

Journal of Bacteriology, June 2005, p. 4104-4115, Vol. 187, No. 12
0021-9193/05/$08.00+0     doi:10.1128/JB.187.12.4104-4115.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Gu, X., Wages, C. J., Davis, K. E., Guyett, P. J., Bar-Peled, M. (2009). Enzymatic Characterization and Comparison of Various Poaceae UDP-GlcA 4-Epimerase Isoforms. J Biochem 146: 527-534 [Abstract] [Full Text]  
  • Miller, W. L., Matewish, M. J., McNally, D. J., Ishiyama, N., Anderson, E. M., Brewer, D., Brisson, J.-R., Berghuis, A. M., Lam, J. S. (2008). Flagellin Glycosylation in Pseudomonas aeruginosa PAK Requires the O-antigen Biosynthesis Enzyme WbpO. J. Biol. Chem. 283: 3507-3518 [Abstract] [Full Text]  
  • Frirdich, E., Bouwman, C., Vinogradov, E., Whitfield, C. (2005). The Role of Galacturonic Acid in Outer Membrane Stability in Klebsiella pneumoniae. J. Biol. Chem. 280: 27604-27612 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frirdich, E.
Right arrow Articles by Whitfield, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frirdich, E.
Right arrow Articles by Whitfield, C.

Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»